查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1984177

NGS试剂盒市场：2026-2032年全球市场预测（按产品类型、定序技术、样本类型、应用和最终用户划分）

NGS Kits Market by Product Type, Sequencing Technology, Sample Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

NGS试剂盒市场预计到2025年将达到28.2亿美元，到2026年将成长到31.7亿美元，到2032年将达到66.5亿美元，复合年增长率为13.03%。

主要市场统计数据
基准年 2025 28.2亿美元
预计年份：2026年 31.7亿美元
预测年份 2032 66.5亿美元
复合年增长率 (%) 13.03%

对定序盒在研究和临床环境中实现稳健的基因组和转录组分析工作流程方面不断演变的作用进行了权威说明。

次世代定序盒是基础工具，可在科研、临床和工业领域实现高解析度的基因组、转录组和表观基因分析。这些试剂盒包含试剂、耗材和样品製备流程，用于将生物样品转化为定序的文库和模板，其性能特征显着影响下游数据的品质和可解释性。随着定序应用的日益多样化，试剂盒设计也在不断发展，优先考虑柔软性、通量适应性和最大限度减少人工干预，从而支持更广泛的实验设计，从靶向测序到全基因组分析。

化学、自动化和平台相容性的创新整合正在重新定义定序盒，并改变整个基因组学领域的实验工作流程。

定序盒领域正经历一场变革，这得益于化学定序、奈米孔定序和合成定序等读取技术的平行发展，以及单细胞定序和长读长定序应用的日趋成熟。传统的定序流程着重于逐步提高读取准确性和通量，而近期的进展已将重点转向通用性和端到端流程最佳化。例如，样品製备变得更加模组化，使得实验室能够在不大幅改变通讯协定的情况下调整起始样本量和富集策略。同时，模板製备和基于PCR的扩增技术的改进提高了定序结果的均一性并降低了偏差，尤其是在复杂基因组和低起始样本的情况下。

评估近期关税变化对营运和供应链的影响，以及对定序盒采购韧性和供应商策略的影响。

贸易政策的变化，包括关税调整，正对定序盒的采购和分销产生切实的影响，尤其对于那些跨境采购试剂、耗材和仪器兼容配件的企业而言更是如此。关税正在改变最终成本，促使企业重新评估其供应商组合，采用替代物流策略，或将部分生产活动在地化，以维持可靠的供应和可预测的奖励。因此，采购团队和销售经理正在审查与供应商的合同，并探索降低成本大幅上涨风险的合约机制。同时，监管和海关合规部门也在加强文件流程，以避免运输延误。

将产品类型、应用需求、最终用户画像和定序技术与策略性试剂盒设计和部署联繫起来的全面细分洞察。

详细的细分阐明了构成定序试剂盒生态系统的各个产品配置和使用者需求。产品类型分为样品製备盒、定序试剂盒和模板建构试剂盒。样品製备盒进一步细分为扩增子特异性试剂盒、RNA定序优化试剂盒和全基因组文库解决方案。定序试剂盒类型包括边合成边定序（SBS）配方以及奈米孔导向的化学系统，其中奈米孔试剂本身又分为生物奈米孔试剂和固相奈米孔试剂。模板建构流程包括桥接PCR和乳液PCR两种方法，每种方法对通量和应用领域的影响各不相同。

区域战略观点与美洲、欧洲、中东、非洲和亚太市场不同的监管、基础设施和采购现实相一致。

区域趋势影响着三大主要地区定序盒的需求模式、法规要求和供应链结构。在美洲，强大的学术网络和成熟的临床诊断市场推动了对优先考虑合规性、可重复性和与现有仪器基础设施整合的试剂盒的需求。采购流程受到机构采购週期和关键试剂国内生产能力的影响，因此，及时的技术支援和检验的通讯协定成为决定性采购标准。

透过产品组合整合、供应链弹性和端到端解决方案交付来决定成功的关键竞争对手和企业策略。

定序盒产业的企业策略日益取决于其产品组合的广度、技术支援水准以及提供整合工作流程的能力，从而降低应用门槛。主要企业优先考虑与多种定序平台的兼容性，同时投资于配方改进，以延长保质期并简化通讯协定流程。与仪器製造商、自动化供应商和生物资讯解决方案供应商建立策略合作伙伴关係，透过建构满足湿实验室和数据驱动型需求的端到端解决方案，进一步提升了价值提案。

为製造商和供应商提供切实可行的策略建议，以增强韧性、扩大部署范围，并将定序盒快速整合到复杂的实验室工作流程中。

产业领导企业可以采取实际措施来巩固其市场地位，并应对技术和政策主导的变化。首先，优先考虑供应链多元化，并为关键试剂和耗材建立双重采购安排，可降低贸易中断的风险。其次，投资区域製造可缩短前置作业时间，提高服务应对力。第三，投资模组化试剂盒架构和自动化平台的标准化接口，可以扩大目标客户群，并降低高通量实验室的整合门槛。

结合与主要相关人员的对话、技术检验和供应链分析，采用稳健、全面的调查方法，为决策者提供可操作且可靠的见解。

本研究整合了多层次调查方法所获得的洞见，该方法结合了与关键相关人员的对话、严谨的二手资料研究和技术检验。主要研究包括对研究主管、采购负责人、产品经理和法规遵循专家进行深入访谈，以获取关于营运重点、挑战和推广驱动因素的第一手观点。此外，还对技术文献、法规指导文件和产品规格进行了全面审查，以准确反映试剂盒的化学特性、工作流程依赖性和合规性考量，从而补充了这些定性资讯。

结论明确了相关人员在应对定序试剂盒创新、监管和供应链的复杂性时应优先考虑的策略重点。

简而言之，定序盒在实现高品质基因组和转录组分析中发挥着至关重要的作用，随着其应用领域和平台的日益多元化，其策略重要性也与日俱增。能够根据特定应用需求客製化产品设计、投资供应链韧性并提供与自动化和数据工作流程检验整合的製造商和经销商，将更有能力满足科学研究和临床领域客户不断变化的需求。政策和贸易情势的变化凸显了灵活筹资策略和透明沟通对于降低中断风险的必要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第8章 NGS试剂盒市场：依产品类型划分

  • 样品製备工具包
    • DNA样品製备盒
    • RNA样品製备盒
  • 定序盒
  • 模板製备工具包

第九章：依定序技术分類的NGS试剂盒市场

  • 奈米孔定序
    • 生物奈米孔
    • 固态奈米孔
  • 连接定序
  • 合成定定序
  • 离子半导体定序

第十章检体类型分類的NGS试剂盒市场

  • 血
  • 组织
  • 唾液
  • 微生物样本

第十一章 NGS试剂盒市场：依应用领域划分

  • EXOME定序
    • 临床EXOME定序
    • EXOME定序研究
  • 目标序列
    • 基于杂合反应法的标靶定序
    • 基于PCR的标靶定序
  • 转录组序列
    • 批量RNA定序
    • 单细胞RNA定序
  • 全基因组定序

第十二章 NGS试剂盒市场：依最终用户划分

  • 学术研究机构
  • 临床实验室
  • 製药和生物技术公司

第十三章 NGS试剂盒市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 NGS试剂盒市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 NGS试剂盒市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国NGS试剂盒市场

第十七章：中国NGS试剂盒市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Creative Biogene
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Illumina, Inc.
  • Invivoscribe, Inc.
  • LGC Biosearch Technologies
  • New England Biolabs
  • Oxford Nanopore Technologies plc.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN NV
  • seqWell
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific, Inc.
  • Twist Bioscience Corporation
  • Zymo Research Corporation
Product Code: MRR-5C6F41F5AFEA

The NGS Kits Market was valued at USD 2.82 billion in 2025 and is projected to grow to USD 3.17 billion in 2026, with a CAGR of 13.03%, reaching USD 6.65 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.82 billion
Estimated Year [2026] USD 3.17 billion
Forecast Year [2032] USD 6.65 billion
CAGR (%) 13.03%

An authoritative introduction to the evolving role of sequencing kits in enabling robust genomic and transcriptomic workflows across research and clinical environments

Next-generation sequencing kits are foundational tools that enable high-resolution genomic, transcriptomic and epigenomic analysis across research, clinical and industrial settings. These kits encompass reagents, consumables and preparative workflows that convert biological samples into sequencing-ready libraries and templates, and their performance characteristics materially influence downstream data quality and interpretability. As sequencing applications diversify, kit design has evolved to prioritize flexibility, throughput compatibility and minimized hands-on time, supporting a broader range of experimental designs from targeted panels to whole genome interrogation.

Across contemporary laboratory ecosystems, kit providers face escalating expectations for reproducibility, regulatory readiness and integration with automated platforms. Consequently, innovation has concentrated on reducing protocol complexity, improving reagent stability and enabling compatibility with multiple instrument architectures. At the same time, end users demand transparent documentation and robust technical support to reduce adoption friction. This introduction situates sequencing kits within the broader lifecycle of genomic assays, emphasizing how incremental improvements in kit chemistry and workflow ergonomics cumulatively shape experimental outcomes, influence purchasing decisions and inform strategic partnerships across the life sciences value chain.

How converging innovations in chemistry, automation and platform compatibility are redefining sequencing kits and reshaping laboratory workflows across genomics

The landscape for sequencing kits is undergoing transformative shifts driven by concurrent advances in chemistry, nanopore and synthesis-based readout technologies, and the maturation of single-cell and long-read applications. Historically, sequencing workflows emphasized incremental gains in read accuracy and throughput, but recent progress has pivoted attention toward versatility and end-to-end workflow optimization. For example, library preparation has become more modular, enabling labs to tailor input requirements and enrichment strategies without extensive protocol redevelopment. In parallel, improvements in template preparation and PCR-based amplification approaches have enhanced uniformity and reduced bias, particularly for complex genomes and low-input samples.

Moreover, sequencing platform evolution is prompting kit manufacturers to reimagine reagent sets and compatibility matrices. Emergent nanopore chemistries and enhanced sequencing-by-synthesis formulations require bespoke library and sequencing kits that reconcile instrument-specific constraints with user expectations for ease of use. This technological plurality encourages kit developers to adopt platform-agnostic designs or to invest in tight integration with specific instrument ecosystems. At the same time, digital innovations in sample tracking, barcoding and integration with bioinformatics pipelines are transforming what users expect from a kit beyond wet-lab performance, creating a competitive landscape where reagent quality, software interoperability and end-user experience converge.

Assessing the operational and supply chain consequences of recent tariff shifts and their implications for procurement resilience and supplier strategies in sequencing kits

Trade policy shifts, including tariff adjustments, exert a tangible influence on the procurement and distribution dynamics for sequencing kits, particularly for organizations that source reagents, consumables and instrument-compatible accessories across borders. Tariffs alter landed costs and create incentives for firms to reassess supplier portfolios, adopt alternative logistics strategies, or localize certain manufacturing activities to maintain reliable supply and predictable pricing. As a result, procurement teams and commercial leaders are re-evaluating supplier contracts and exploring contractual mechanisms to mitigate exposure to abrupt cost escalations, while regulatory and customs compliance functions are intensifying documentation practices to avoid shipment delays.

In response to new tariff regimes, manufacturers may prioritize regional manufacturing investments or adjust their distribution footprints to preserve service levels for clinical and research customers. These strategic adjustments can lead to modified lead times, revised minimum order requirements and changes in how after-sales support is structured across territories. Importantly, tariff-driven cost pressures also affect the entire value chain, creating incentives for stakeholders to streamline kit formulations, reduce packaging complexity and optimize palletization to lower transportation inefficiencies. These operational adaptations underscore the need for coordinated supply chain resilience planning and the importance of establishing transparent communication channels with end users to manage expectations during periods of trade policy volatility.

Comprehensive segmentation insights that map product types, application demands, end-user profiles and sequencing technologies to strategic kit design and deployment

Detailed segmentation provides clarity on the distinct product configurations and user requirements that define the sequencing kits ecosystem. Product type distinctions separate library preparation kits, sequencing kits and template preparation kits, with library preparation further differentiating amplicon-focused kits, RNA sequencing optimized kits and whole genome library solutions. Sequencing kit varieties include nanopore-oriented chemistries alongside sequencing-by-synthesis formulations, and the nanopore category itself splits into biological nanopore reagents and solid-state implementations. Template preparation workflows capture both bridge PCR and emulsion PCR approaches, each with implications for throughput and application suitability.

Application-based segmentation frames how kits are tailored to specific analytical goals, ranging from exome and targeted sequencing use cases to transcriptome analyses and whole genome interrogation. Exome protocols vary between clinical-grade and research-focused implementations, while targeted strategies encompass hybridization-based enrichment as well as PCR-driven target selection. Transcriptome sequencing includes both bulk RNA and single-cell RNA methodologies, each driving distinct requirements for input handling and amplification fidelity. End-user segmentation emphasizes the different operational demands of academic research institutes, clinical diagnostic laboratories and pharmaceutical or biotechnology companies, and highlights nuance within these categories such as government research centers versus university laboratories, hospital diagnostic facilities versus independent labs, and the distinctions between startup biotechnology firms and established global pharmaceutical companies. Finally, sequencing technology segmentation differentiates core platforms including nanopore, sequencing by ligation and sequencing by synthesis, with further granularity between biological and solid-state nanopore implementations, which influence kit chemistry choices and workflow integration strategies.

Taken together, these segmentation lenses clarify how product design, regulatory readiness and service models must be aligned to the specific needs of applications and end users, enabling manufacturers and distributors to prioritize product roadmaps and technical support offerings that resonate with their target customer segments.

Regional strategic perspectives that reconcile distinct regulatory, infrastructure and procurement realities across Americas, Europe Middle East and Africa and Asia Pacific markets

Regional dynamics shape demand patterns, regulatory requirements and supply chain architectures for sequencing kits across three primary geographies. In the Americas, robust academic networks and a mature clinical diagnostics market drive demand for kits that emphasize regulatory compliance, reproducibility and integration with established instrument bases. Procurement processes are influenced by institutional purchasing cycles and the presence of domestic manufacturing capacity for key reagents, creating a context in which timely technical support and validated protocols are decisive purchasing criteria.

Across Europe, Middle East & Africa, diverse regulatory landscapes and heterogeneous research infrastructures create both challenges and opportunities for kit providers. Harmonization efforts and pan-regional clinical networks increase the appeal of kits with strong documentation, multilingual technical resources and adaptable workflows that can be validated locally. Additionally, emerging biotech hubs in several markets within this region are accelerating adoption of advanced sequencing approaches, prompting suppliers to offer flexible supply arrangements and localized training programs.

In the Asia-Pacific region, rapid expansion of genomic research capabilities and increasing clinical sequencing penetration favor kits that can scale across high-volume operations while remaining cost-effective and robust in varied laboratory settings. Local manufacturing initiatives and government-supported research programs further incentivize suppliers to establish regional presences, co-development partnerships and localized quality systems to meet regulatory expectations and expedite market entry. Collectively, regional considerations underscore the need for geographically informed product strategies and supply chain models that accommodate differing regulatory, infrastructural and commercial realities.

Key competitive dynamics and corporate strategies that determine success through portfolio integration, supply chain resilience and end to end solution offerings

Company strategies within the sequencing kits arena are increasingly defined by portfolio breadth, depth of technical support and the ability to offer integrated workflows that reduce barriers to adoption. Leading kit developers emphasize compatibility with multiple sequencing platforms while investing in formulation improvements that enhance shelf life and reduce protocol complexity. Strategic partnerships with instrument manufacturers, automation vendors and bioinformatics solution providers further extend value propositions by creating end-to-end solutions that address both wet-lab and data-driven needs.

In addition to product innovation, competitive differentiation arises from supply chain reliability and the capacity to deliver validated protocols and training at scale. Companies that maintain transparent quality systems, responsive technical service and clear documentation gain traction among diagnostics laboratories and large research consortia that prioritize reproducibility and regulatory readiness. Moreover, where companies pursue vertical integration-combining reagent production with consumable manufacturing and distribution-they can offer bundled solutions that simplify procurement and support lifecycle management. Finally, an emphasis on modular kit design and application-specific optimization enables firms to capture diverse use cases while minimizing the need for extensive inventory SKUs, supporting both operational efficiency and customer-focused customization.

Actionable strategic recommendations for manufacturers and providers to enhance resilience, broaden adoption and accelerate integration of sequencing kits into complex laboratory workflows

Industry leaders can take concrete actions to strengthen market position and respond to both technological and policy-driven shifts. First, prioritizing supply chain diversification and establishing dual-sourcing arrangements for critical reagents and consumables will reduce vulnerability to trade disruptions, while regional manufacturing investments can shorten lead times and enhance service responsiveness. Second, investing in modular kit architectures and standardized interfaces for automation platforms will broaden addressable customer segments and lower barriers to integration for high-throughput laboratories.

Third, engaging proactively with regulatory bodies and clinical stakeholders to develop validated, documentation-rich kit offerings will accelerate adoption in diagnostic settings and build trust among procurement decision-makers. Fourth, deepening collaboration with instrument and software partners to deliver verified end-to-end workflows will create compelling value propositions that go beyond single-product sales. Finally, cultivating robust post-sale support, including hands-on training, protocol optimization services and rapid technical escalation pathways, will increase customer retention and enable manufacturers to capture customer-driven product improvements through feedback loops that inform iterative innovation.

A robust mixed methodology combining primary stakeholder engagement, technical validation and supply chain analysis to produce practical and reliable insights for decision makers

This research synthesizes insights from a layered methodology that combines primary stakeholder engagement with rigorous secondary analysis and technical validation. Primary research included in-depth interviews with laboratory directors, procurement specialists, product managers and regulatory affairs professionals to capture first-hand perspectives on operational priorities, pain points and adoption drivers. These qualitative inputs were complemented by a comprehensive review of technical literature, regulatory guidance documents and product specification sheets to ensure accurate representation of kit chemistries, workflow dependencies and compliance considerations.

To augment qualitative findings, the analysis incorporated product portfolio mapping, patent landscape assessment and supply chain tracing to identify common manufacturing dependencies and distribution models. Technical validation was achieved through cross-referencing vendor protocol performance claims with independent experimental reports and user feedback, while expert panel reviews provided additional scrutiny of categorizations and strategic implications. Throughout the methodology, emphasis was placed on triangulation and transparency to ensure that conclusions reflect convergent evidence rather than single-source assertions, enabling practical recommendations that are grounded in operational realities.

Concluding perspectives that crystallize the strategic priorities for stakeholders to navigate innovation, regulation and supply chain complexity in sequencing kits

In sum, sequencing kits occupy a pivotal role in enabling high-quality genomic and transcriptomic assays, and their strategic importance is increasing as applications diversify and platform plurality expands. Manufacturers and distributors who align product design with application-specific needs, invest in supply chain resilience, and offer verifiable integration with automation and data workflows will be best positioned to meet the evolving expectations of research and clinical customers. Policy and trade developments underscore the need for flexible sourcing strategies and transparent communication to mitigate disruption risks.

Looking ahead, the most successful organizations will balance rapid innovation in kit chemistries and workflows with a relentless focus on reproducibility, regulatory alignment and post-sale support. By doing so, they can not only address current operational constraints but also enable laboratories to adopt more ambitious experimental designs that drive scientific and clinical advances. This conclusion highlights the strategic imperatives that should guide R&D prioritization, commercial planning and customer engagement across the sequencing kits ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. NGS Kits Market, by Product Type

  • 8.1. Library Preparation Kits
    • 8.1.1. DNA Library Prep Kits
    • 8.1.2. RNA Library Prep Kits
  • 8.2. Sequencing Kits
  • 8.3. Template Preparation Kits

9. NGS Kits Market, by Sequencing Technology

  • 9.1. Nanopore Sequencing
    • 9.1.1. Biological Nanopore
    • 9.1.2. Solid-State Nanopore
  • 9.2. Sequencing By Ligation
  • 9.3. Sequencing By Synthesis
  • 9.4. Ion Semiconductor Sequencing

10. NGS Kits Market, by Sample Type

  • 10.1. Blood
  • 10.2. Tissue
  • 10.3. Saliva
  • 10.4. Microbial Samples

11. NGS Kits Market, by Application

  • 11.1. Exome Sequencing
    • 11.1.1. Clinical Exome Sequencing
    • 11.1.2. Research Exome Sequencing
  • 11.2. Targeted Sequencing
    • 11.2.1. Hybridization Based Targeted Sequencing
    • 11.2.2. PCR Based Targeted Sequencing
  • 11.3. Transcriptome Sequencing
    • 11.3.1. Bulk RNA Sequencing
    • 11.3.2. Single Cell RNA Sequencing
  • 11.4. Whole Genome Sequencing

12. NGS Kits Market, by End User

  • 12.1. Academic Research Institute
  • 12.2. Clinical Diagnostic Laboratories
  • 12.3. Pharmaceutical Biotechnology Companies

13. NGS Kits Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. NGS Kits Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. NGS Kits Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States NGS Kits Market

17. China NGS Kits Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies, Inc.
  • 18.6. BGI Group
  • 18.7. Bio-Rad Laboratories, Inc.
  • 18.8. Creative Biogene
  • 18.9. Danaher Corporation
  • 18.10. Eurofins Scientific SE
  • 18.11. F. Hoffmann-La Roche Ltd
  • 18.12. Hologic, Inc.
  • 18.13. Illumina, Inc.
  • 18.14. Invivoscribe, Inc.
  • 18.15. LGC Biosearch Technologies
  • 18.16. New England Biolabs
  • 18.17. Oxford Nanopore Technologies plc.
  • 18.18. Pacific Biosciences of California, Inc.
  • 18.19. PerkinElmer Inc.
  • 18.20. Promega Corporation
  • 18.21. QIAGEN N.V.
  • 18.22. seqWell
  • 18.23. Takara Bio Inc.
  • 18.24. Tecan Trading AG
  • 18.25. Thermo Fisher Scientific, Inc.
  • 18.26. Twist Bioscience Corporation
  • 18.27. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NGS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NGS KITS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NGS KITS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NGS KITS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NGS KITS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NGS KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NGS KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NGS KITS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NGS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NGS KITS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NGS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NGS KITS MARKET SIZE, BY DNA LIBRARY PREP KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NGS KITS MARKET SIZE, BY DNA LIBRARY PREP KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NGS KITS MARKET SIZE, BY DNA LIBRARY PREP KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NGS KITS MARKET SIZE, BY RNA LIBRARY PREP KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NGS KITS MARKET SIZE, BY RNA LIBRARY PREP KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NGS KITS MARKET SIZE, BY RNA LIBRARY PREP KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NGS KITS MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NGS KITS MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NGS KITS MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NGS KITS MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NGS KITS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NGS KITS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NGS KITS MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NGS KITS MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NGS KITS MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NGS KITS MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NGS KITS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NGS KITS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NGS KITS MARKET SIZE, BY MICROBIAL SAMPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NGS KITS MARKET SIZE, BY MICROBIAL SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NGS KITS MARKET SIZE, BY MICROBIAL SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NGS KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS NGS KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL NGS KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. GCC NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GCC NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 200. GCC NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. GCC NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 202. GCC NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. GCC NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 205. GCC NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 206. GCC NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 207. GCC NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. G7 NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. G7 NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 233. G7 NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. G7 NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 235. G7 NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. G7 NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. G7 NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 238. G7 NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 239. G7 NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 240. G7 NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. NATO NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. NATO NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 244. NATO NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 246. NATO NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. NATO NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 249. NATO NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 250. NATO NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 251. NATO NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES NGS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA NGS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)